BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21764905)

  • 1. Exon 11 skipping of E-cadherin RNA downregulates its expression in head and neck cancer cells.
    Sharma S; Liao W; Zhou X; Wong DT; Lichtenstein A
    Mol Cancer Ther; 2011 Sep; 10(9):1751-9. PubMed ID: 21764905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors.
    Jordaan G; Liao W; Sharma S
    BMC Cancer; 2013 Feb; 13():88. PubMed ID: 23432814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer.
    Li XW; Shi BY; Yang QL; Wu J; Wu HM; Wang YF; Wu ZJ; Fan YM; Wang YP
    BMC Cancer; 2015 Dec; 15():954. PubMed ID: 26674321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
    Jpn J Cancer Res; 1996 Nov; 87(11):1153-9. PubMed ID: 9045944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells.
    Sharma S; Lichtenstein A
    Blood; 2009 Nov; 114(19):4179-85. PubMed ID: 19745069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.
    Qian W; Liang H; Shi J; Jin N; Grundke-Iqbal I; Iqbal K; Gong CX; Liu F
    Nucleic Acids Res; 2011 Aug; 39(14):6161-71. PubMed ID: 21470964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of epigenetic histone modifications on E-cadherin splicing and expression in lung cancer.
    Liao W; Jordaan G; Srivastava MK; Dubinett S; Sharma S; Sharma S
    Am J Cancer Res; 2013; 3(4):374-89. PubMed ID: 23977447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35.
    Shi J; Hu Z; Pabon K; Scotto KW
    Mol Cell Biol; 2008 Jan; 28(2):883-95. PubMed ID: 18025108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene.
    Huang SC; Cho A; Norton S; Liu ES; Park J; Zhou A; Munagala ID; Ou AC; Yang G; Wickrema A; Tang TK; Benz EJ
    Blood; 2009 Nov; 114(19):4233-42. PubMed ID: 19729518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis.
    Moller-Levet CS; Betts GN; Harris AL; Homer JJ; West CM; Miller CJ
    PLoS Comput Biol; 2009 Nov; 5(11):e1000571. PubMed ID: 19936049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR.
    Wang D; Su L; Huang D; Zhang H; Shin DM; Chen ZG
    Mol Cancer; 2011 Sep; 10():116. PubMed ID: 21939503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
    Lemaire R; Winne A; Sarkissian M; Lafyatis R
    Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spheroid-based 3-dimensional culture models: Gene expression and functionality in head and neck cancer.
    Schmidt M; Scholz CJ; Polednik C; Roller J
    Oncol Rep; 2016 Apr; 35(4):2431-40. PubMed ID: 26797047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone deficiency and splicing fidelity: two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically.
    Solis AS; Peng R; Crawford JB; Phillips JA; Patton JG
    J Biol Chem; 2008 Aug; 283(35):23619-26. PubMed ID: 18586677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
    Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
    J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells.
    Oh J; Pradella D; Shao C; Li H; Choi N; Ha J; Ruggiero S; Fu XD; Zheng X; Ghigna C; Shen H
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.